CYCC stock forecast for 2023 – 2027
Last updated: April 25, 2024
Are you interested in Cyclacel Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CYCC stock price in 2022-2027. Is CYCC a good long term stock? When should I take profit in Cyclacel Pharmaceuticals stock? Buy or sell stock? Will CYCC stock price go up? What are analysts’ forecasts for CYCC stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CYCC stock returns are also predicted based on historical data.
According to our research, CYCC stock is a bad long-term investment. CYCC share price has been in a bear cycle for the past year. Cyclacel Pharmaceuticals, Inc. stock trend is negative.
Cyclacel Pharmaceuticals company info
| Industry | Biotechnology |
| Address | 200 Connell Drive, Berkeley Heights, NJ, 07922, United States |
| Website | https://www.cyclacel.com |
Forecasting
52 Week High: 17.5381 USD
52 Week Low: 0.00042532 USD
1 Year Forecast: 2.63439 USD
5 Year Forecast: 3.24576 USD
Agilent Technologies info
Market Cap: 31.72M
52 Week Change: -4.0227%
52 Week High: 11.42 USD
52 Week Low: 2.76 USD
Beta: 1.66881
50 Day Moving Average: 3.59
90 Day Moving Average: 3.858
200 Day Moving Average: 4.67
Resistance Level: 3.3229
Pivot Point: 3.1262
Support Level: 3.11
Enterprise Value: 425,799
Forward P/E: -1.06
Forward EPS: -2.9
Profit Margin: 0.00%
Shares Outstanding: 9,975,140
EBITDA: -0.02
Held Percent Institutions: 44.58%
PEG Ratio (5Y): 0
Trailing EPS: -2.657
Cyclacel Pharmaceuticals stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Cyclacel Pharmaceuticals Stock Forecast for 2023 | |||
| January 2023 | 0 | 2 | 0% |
| February 2023 | 2.04 | 7.14 | 250% |
| March 2023 | 5.94 | 14.85 | 150% |
| April 2023 | 15.84 | 14.14 | -10.73% |
| May 2023 | 14 | 8.91 | -36.36% |
| June 2023 | 8.91 | 6.06 | -31.99% |
| July 2023 | 6 | 4.08 | -32% |
| August 2023 | 3.92 | 0 | -100% |
| September 2023 | 1 | 0 | -100% |
| October 2023 | 0 | 0 | -100% |
| November 2023 | 0 | 0 | -100% |
| December 2023 | 0 | 0 | -100% |
Cyclacel Pharmaceuticals Stock Forecast for 2024 | |||
| January 2024 | 0 | 1.98 | -100% |
| February 2024 | 2.02 | 6 | 197.03% |
| March 2024 | 6.86 | 15.15 | 120.85% |
| April 2024 | 15.68 | 14.14 | -9.82% |
| May 2024 | 14.14 | 9.18 | -35.08% |
| June 2024 | 9.18 | 6.93 | -24.51% |
| July 2024 | 6.12 | 3.96 | -35.29% |
| August 2024 | 4.04 | 1 | -75.25% |
| September 2024 | 0 | 0 | -75.25% |
| October 2024 | 0 | 0 | -75.25% |
| November 2024 | 0 | 0 | -75.25% |
| December 2024 | 0 | 0 | -75.25% |
Cyclacel Pharmaceuticals Stock Forecast for 2025 | |||
| January 2025 | 0 | 3.03 | -75.25% |
| February 2025 | 2 | 6.86 | 243% |
| March 2025 | 6.06 | 14.7 | 142.57% |
| April 2025 | 14.85 | 14 | -5.72% |
| May 2025 | 13.72 | 8.91 | -35.06% |
| June 2025 | 9.09 | 6 | -33.99% |
| July 2025 | 5.05 | 3.92 | -22.38% |
| August 2025 | 4.04 | 1.01 | -75% |
| September 2025 | 0 | 0 | -75% |
| October 2025 | 0 | 0 | -75% |
| November 2025 | 0 | 0 | -75% |
| December 2025 | 0 | 0 | -75% |
Cyclacel Pharmaceuticals Stock Forecast for 2026 | |||
| January 2026 | 0 | 3 | -75% |
| February 2026 | 2.02 | 6.93 | 243.07% |
| March 2026 | 6.12 | 15.3 | 150% |
| April 2026 | 15.3 | 13.72 | -10.33% |
| May 2026 | 13.72 | 9 | -34.4% |
| June 2026 | 9 | 5.88 | -34.67% |
| July 2026 | 4.95 | 3.92 | -20.81% |
| August 2026 | 3.03 | 0 | -100% |
| September 2026 | 0 | 0 | -100% |
| October 2026 | 0 | 0 | -100% |
| November 2026 | 0 | 0 | -100% |
| December 2026 | 0 | 0 | -100% |
Cyclacel Pharmaceuticals Stock Forecast for 2027 | |||
| January 2027 | 0 | 2.97 | -100% |